Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

Basit Öğe Kaydı
dc.contributor.authorBeypinar, Ismail
dc.contributor.authorAraz, Murat
dc.date.accessioned2024-02-23T14:17:03Z
dc.date.available2024-02-23T14:17:03Z
dc.date.issued2023
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.doi10.1056/NEJMc2306786
dc.identifier.endpage478en_US
dc.identifier.issn0028-4793
dc.identifier.issn1533-4406
dc.identifier.issue5en_US
dc.identifier.pmid37530832en_US
dc.identifier.scopus2-s2.0-85166143198en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage476en_US
dc.identifier.urihttps://doi.org/10.1056/NEJMc2306786
dc.identifier.urihttps://hdl.handle.net/20.500.12452/12919
dc.identifier.volume389en_US
dc.identifier.wosWOS:001086308700018en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMassachusetts Medical Socen_US
dc.relation.ispartofNew England Journal Of Medicineen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleCabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinomaen_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu